Immune-based therapies in cardiovascular and metabolic diseases: past, present and future

Volume: 21, Issue: 10, Pages: 669 - 679
Published: Jul 20, 2021
Abstract
Cardiometabolic disorders were originally thought to be driven primarily by changes in lipid metabolism that cause the accumulation of lipids in organs, thereby impairing their function. Thus, in the setting of cardiovascular disease, statins - a class of lipid-lowering drugs - have remained the frontline therapy. In the past 20 years, seminal discoveries have revealed a central role of both the innate and adaptive immune system in driving...
Paper Details
Title
Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
DOI
Published Date
Jul 20, 2021
Journal
Volume
21
Issue
10
Pages
669 - 679
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.